Dodo, Juvelyn .

HRN: 22-44-53  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2023
CEFUROXIME 1.5GM (VIAL)
04/10/2023
04/11/2023
IVT
1.5g
Q8H X 2 Doses
S/P Repeat CS
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: